Advanced Medical Optics
| subsidiary | |
| Industry | Ophthalmology |
| Founded | Santa Ana, California 2002 |
| Headquarters | Santa Ana, California |
|
Key people
|
Tom Frinzi, President, Michael J. Lambert, CFO |
| Products |
Ophthalmic pharmaceuticals Surgical equipment Contact care products |
|
Number of employees
|
3,800 |
| Parent | Abbott Laboratories |
| Website | http://www.amo-inc.com/ |
Abbott Medical Optics Inc. earlier known as Advanced Medical Optics, Inc. (also known as AMO) is a global medical supply company. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
AMO, (originally Heyer-Schulte Medical Optics, renamed American Medical Optics after purchase by American Hospital Supply Corporation - AHSC) started business in 1976 in the early development of intraocular lenses for cataract patients.
In 1983 American Medical Optics, the Santa Ana eye product division of American Hospital Supply Corp., began to manufacture the tissue lens.
In 1986, Allergan acquired American Medical Optics, and as Allergan Medical Optics, continued to manufacture the lenticules.
AMO was spun off from Allergan in 2002.
AMO acquired VisX Inc. in a stock and cash transaction valued at approximately $1.27 billion, in November 2004. The combined company retained the Advanced Medical Optics name and AMO’s Santa Ana, Calif., headquarters. The laser franchise retained the VisX brand name, and VisX continued manufacturing and research and development activities at its Santa Clara, Calif., site. The AMO portfolio already included the Amadeus II microkeratome, the Verisyse phakic IOL, and the ReZoom, Array and Tecnis IOLs in that time.
In Jan. 16, 2007 AMO announced the acquisition of privately held WaveFront Sciences Inc., a provider of wavefront diagnostic systems for refractive surgery and medical research, for $20 million in cash.
AMO acquired Irvine-based IntraLase Corp. for $808 million in January 2007. This allowed AMO to combine IntraLase technology for cutting a flap in the cornea with AMO technology for reshaping the cornea. The combination of these complementary technologies has made "all-laser LASIK" possible. NASA later approved this all-laser LASIK for use on astronauts.
In August 2007 the company donated $2.5 million to UC-Irvine's Department of Ophthalmology to boost the university's planned Eye Institute.
On February 26, 2009 Abbott Laboratories announced that it had completed its acquisition of Advanced Medical Optics (AMO) in a $2.8 billion deal. AMO had become a wholly owned subsidiary of Abbott and was renamed Abbott Medical Optics Inc.
In September 2016, pharmaceutical and medical device company Johnson & Johnson announced they were buying Abbott Medical Optics for $4.3 billion.
...
Wikipedia